Sharpmed, LLC is thrilled to announce it acquired a key respiratory product patent. This patent adds to the growing portfolio for our device called Turbo® O₂ Cap. “This patent is key for our strategy of becoming the future market leader for devices to reduce/eliminate hypoxia during difficult intubations and may become the standard of care” – Dr Chris Salvino, MD, CEO.